MedTrace Logo

Cross-cultural Adaptation and Validation of the P-CIN for Chinese Pediatric Oncology Patients

NCT07053579 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 313

Last updated 2025-07-08

No results posted yet for this study

Summary

The goal of this study was to conduct a cross-cultural adaptation of the P-CIN into the Chinese context, assess its psychometric properties, and determine the cut-off value of CIPN among Chinese pediatric oncology patients.

Participants provided demographic and clinical characteristics, and complete the translated P-CIN, Wong-baker FACES Pain Rating scale for pain, and Chinese version of the Pediatric Quality of Life Inventory (PedsQL) Cancer Module for quality of life.

Conditions

  • Pediatric Cancer

Sponsors & Collaborators

  • Shanghai Children's Medical Center

    collaborator OTHER

  • Shenzhen Children's Hospital

    collaborator OTHER_GOV

  • The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital

    collaborator UNKNOWN

  • The Hong Kong Polytechnic University

    lead OTHER

Principal Investigators

  • Ka Yan Ho, PhD · The Hong Kong Polytechnic University

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-05
Primary Completion
2025-05-30
Completion
2025-05-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07053579 on ClinicalTrials.gov